| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e472f2bbbe26fba07e9ed0dccb82c2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e389806e879cb6e9f96e85f07b8a109a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F2438-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F2438-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L33-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 |
| filingDate |
2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b526e26bb381feafd469b694e2181ae4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dee28ae238b893b412107bc071f5f9cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7641362a8c37595f76986dfabd0222e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da739e2fd5b9a6a0238516b39ea1e611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0c3d19932be9a8eb4e760d5fa014dbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d35472a4b02fa70002f5b73e26e040a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96ff9a39da87595451c206d6d02e3b09 |
| publicationDate |
2016-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PL-412654-A1 |
| titleOfInvention |
Use of a block polymer containing a block of poly (3-methacryloylaminopropyltrimethylammonium chloride) (PMAPTAC) to neutralize heparin |
| abstract |
The present invention relates to the use of block polymers containing a block of poly (3-methacryloylaminopropyltrimethylammonium chloride) for direct neutralization of heparins in blood and body fluids, especially unfractionated heparin and low molecular weight heparin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-424871-A1 |
| priorityDate |
2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |